Latest On Titan Medical Inc (TMDI):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-03-09 23:16 EST | News | Titan Medical falls after receiving Nasdaq notice about delisting | N/A |  |
| 2023-02-14 14:03 EST | News | Titan Medical lays off senior leadership team; gets Nasdaq non-compliance notice | N/A | |
| 2023-02-08 13:02 EST | News | Titan Medical to lay off staff as asset sale takes priority | N/A | |
| 2022-12-29 08:53 EST | News | Titan Medical receives Nasdaq notice, requests hearing | N/A | |
| 2022-11-10 23:59 EST | News | Titan Medical GAAP EPS of -$0.09 | N/A | |
| 2022-11-10 23:59 EST | News | Titan Medical Inc. (TMDI) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-08-11 16:24 EST | News | Titan Medical Inc. (TMDI) CEO Cary Vance on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-06-30 18:09 EST | News | Titan Medical appoints CEO | N/A | |
| 2022-06-30 00:04 EST | News | Titan Medical granted 180-day extension to regain compliance with Nasdaq's minimum bid price rule | N/A | |
| 2022-06-21 16:05 EST | News | Titan teams up with Nissha Medical to advance Enos surgical system | N/A | |
| 2022-05-13 01:32 EST | News | Titan Medical Inc. (TMDI) CEO Paul Cataford on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-12 05:27 EST | News | Titan Medical Q1 2022 Earnings Preview | N/A | |
| 2022-05-03 21:17 EST | News | Titan Medical rallies on purchase order from Medtronic | N/A | |
| 2022-03-25 01:28 EST | News | Titan Medical Inc. (TMDI) CEO Paul Cataford On Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-03-25 01:27 EST | News | Titan Medical stock falls 6% amid FY21 results | N/A | |
| 2022-03-23 14:44 EST | News | Titan Medical FY Earnings Preview | N/A | |
| 2022-01-27 04:07 EST | News | Titan Medical gets $8.3M from Medtronic under licensing agreement | N/A | |
| 2021-12-31 12:10 EST | News | Titan Medical receives Nasdaq notification for minimum bid price requirement | N/A | |
| 2021-12-05 09:17 EST | News | Titan Medical: Developing Single-Access Robotic Assisted Surgical Technologies | N/A | |
| 2021-12-02 05:54 EST | News | Titan Medical announces resignation of CEO | N/A | |
| 2021-11-11 14:01 EST | News | Titan Medical falls 19% as it needs more time for application for Enos surgical system | N/A | |
| 2021-11-11 14:01 EST | News | Titan Medical Inc.'s (TMDI) CEO David McNally on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-10 16:48 EST | News | Warning: TMDI is at high risk of performing badly | N/A | |
| 2021-08-12 04:48 EST | News | Titan Medical's (TMDI) CEO David McNally on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-07-22 03:52 EST | News | Titan Medical earns milestone payment of $10M under licensing deal with Medtronic; shares rise 10% | N/A | |
| 2021-07-22 03:22 EST | News | Titan Medical names Stephen Lemieux chief financial officer | N/A | |
| 2021-04-23 21:38 EST | News | Titan Medical (TMDI) Investor Presentation - Slideshow | N/A | |
| 2021-04-07 22:23 EST | News | Fibrogen hurt by downgrades, Emergent earns a bull despite vaccine mix-up and more in today’s analyst action | N/A | |
| 2021-03-10 00:26 EST | News | Titan Medical provides corporate update ahead of investor conference | N/A | |
| 2021-02-26 12:30 EST | Financials | Company financials have been released. | Neutral | |
| 2021-02-23 03:39 EST | News | Titan Medical Inc. (TMDI) CEO David McNally on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2021-02-22 09:56 EST | News | Titan Medical reports FY results | N/A | |
| 2021-02-03 07:52 EST | News | Titan Medical announces $15M bought deal offering | N/A | |
| 2021-01-05 21:10 EST | News | Titan Medical announces $10M bought deal offering | N/A | |
| 2020-12-30 14:25 EST | News | Titan medical provides regulatory update on its Enos Robotic Single Access System | N/A | |
| 2020-12-24 12:39 EST | News | Titan Medical in full compliance with Nasdaq listing criteria | N/A | |
| 2020-11-26 21:47 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-18 13:34 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-17 21:00 EST | News | Titan Medical reports Q3 results | N/A | |
| 2020-11-08 01:05 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 17:20 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-27 02:51 EST | News | Titan Medical +18% on $10M payment to be received from Medtronic | N/A | |
| 2020-09-26 14:14 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-18 18:40 EST | News | Titan Medical bags two new patents in U.S. | N/A | |
| 2020-09-17 06:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-09 01:19 EST | News | Titan Medical CFO retires, new chief appointed | N/A | |
| 2020-08-15 09:48 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 10:20 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-13 01:50 EST | News | Titan Medical reports Q2 results | N/A | |
| 2020-08-06 09:42 EST | Financials | Company financials have been released. | Neutral | |
About Titan Medical Inc (TMDI):
Titan Medical Inc., a research and development stage company, focuses on the design, development, and commercialization of computer-assisted robotic surgical technologies for application in minimally invasive surgery (MIS). The company is developing the SPORT Surgical System, a single-port robotic surgical system that comprises a surgeon-controlled patient cart, which includes a 3D high definition vision system and multi-articulating instruments for performing MIS procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during MIS procedures. The SPORT Surgical System enables surgeons to perform surgical procedures for gynecologic, urologic, colorectal, and abdominal indications. Titan Medical Inc. is headquartered in Toronto, Canada.
General
- Name Titan Medical Inc
- Symbol TMDI
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryMedical Devices
- Last Split Factor1:30
- Last Split Date2018-06-19
- Fiscal Year EndDecember
- IPO Date2009-06-26
- Gic SectorHealth Care
- Gic GroupHealth Care Equipment & Services
- Gic IndustryHealth Care Equipment & Supplies
- Gic SubIndustryHealth Care Equipment
- Web URLhttp://www.titanmedicalinc.com
View More
Valuation
- Trailing PE 7.36
- Price/Sales (Trailing 12 Mt.) 7.14
- Price/Book (Most Recent Quarter) 70.89
- Enterprise Value Revenue 9.9
- Enterprise Value EBITDA 535.61
View More
Financials
- Most Recent Quarter 2020-12-31
- Profit Margin -121%
- Operating Margin 21%
- Return on Assets 16%
- Revenue 20 million
- Earnings Per Share -$2.49
- Revenue Per Share $0.3
- Gross Profit 20 million
- Quarterly Earnings Growth 0%
View More
Highlights
- Market Capitalization 204.48 million
- EBITDA 4.33 million
- Book Value Per Share $0.05
View More
Share Statistics
- Shares Outstanding 109.53 million
- Shares Float 99.81 million
- % Held by Insiders 31%
- % Held by Institutions 3.29%
- Shares Short 1.46 million
- Shares Short Prior Month 2.52 million
- Short Ratio 0.37
- Short % of Float 1%
- Short % of Shares Outstanding 1%
View More
Technicals
- Beta 4.68
- 52 Week High $3.47
- 52 Week Low $0.15
- 50 Day Moving Average 2.45
- 200 Day Moving Average 1.45
View More
Dividends
- Dividend Date 2018-06-19
- ExDividend Date N/A
- Dividend Yield 0%
View More
Titan Medical Inc (TMDI) Dividend Calendar:
TMDI's last dividend payment was made to shareholders on June 19, 2018.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Titan Medical Inc (TMDI) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-22 | $10 million | -$0.25 | ||
| 2020-09-30 | 2020-12-31 | $N/A | -$0.25 | ||
| 2020-06-30 | 2020-09-30 | $10 million | -$0.02 | ||
| 2020-03-31 | 2020-06-30 | $N/A | -$0.02 | ||
| 2019-12-31 | 2020-03-31 | $N/A | -$0.02 | -$0.20 | 91.13% |
| 2019-09-30 | 2019-11-14 | $N/A | -$0.05 | -$0.48 | 89.47% |
| 2019-06-30 | 2019-07-31 | $N/A | -$0.46 | -$0.70 | 33.81% |
| 2019-03-31 | 2019-05-14 | $N/A | -$1.22 | -$0.64 | -90.63% |
| 2018-12-31 | 2019-02-13 | $N/A | -$0.41 | -$0.62 | 33.87% |
| 2018-09-30 | 2018-11-12 | $N/A | -$0.41 | -$0.62 | 33.87% |
| 2018-06-30 | 2018-08-13 | $N/A | -$0.43 | -$0.58 | 25.86% |
| 2018-03-31 | 2018-05-14 | $N/A | -$0.06 | ||
| 2017-12-31 | 2018-02-13 | $N/A | -$1.20 | ||
| 2017-09-30 | 2017-11-09 | $N/A | -$1.65 | ||
| 2017-06-30 | 2017-08-08 | $N/A | -$0.30 | -$1.52 | 80.26% |
| 2017-03-31 | 2017-05-11 | $N/A | -$1.20 | -$1.23 | 2.44% |
| 2016-12-31 | 2017-03-21 | $N/A | -$0.30 | -$1.20 | 75% |
| 2016-09-30 | 2016-11-08 | $N/A | -$0.33 | ||
| 2016-06-30 | 2016-08-15 | $N/A | -$1.62 | ||
| 2016-03-31 | 2016-05-16 | $N/A | -$2.85 | ||
| 2015-12-31 | 2016-03-30 | $N/A | -$3.78 | ||
| 2015-09-30 | 2015-11-13 | $N/A | -$3.18 | ||
| 2015-06-30 | 2015-08-11 | $N/A | -$2.41 | ||
| 2015-03-31 | 2015-05-12 | $N/A | -$2.67 | ||
| 2014-12-31 | 2015-02-10 | $N/A | $0.06 | ||
| 2014-09-30 | 2014-09-30 | $N/A | -$0.97 | ||
| 2014-06-30 | 2014-06-30 | $N/A | -$2.12 | ||
| 2014-03-31 | 2014-03-31 | $N/A | -$1.41 | ||
| 2013-12-31 | 2013-12-31 | $N/A | -$0.86 | ||
| 2013-09-30 | 2013-09-30 | $N/A | -$0.87 | ||
| 2013-06-30 | 2013-06-30 | $N/A | -$0.96 | ||
| 2013-03-31 | 2013-03-31 | $N/A | -$1.11 | ||
| 2012-12-31 | 2012-12-31 | $N/A | -$0.88 | ||
| 2012-09-30 | 2012-09-30 | $N/A | -$0.52 | ||
| 2012-06-30 | 2012-06-30 | $N/A | -$0.67 | ||
| 2012-03-31 | 2012-03-31 | $N/A | -$1.59 | ||
| 2011-12-31 | 2011-12-31 | $N/A | -$2.79 | ||
| 2011-09-30 | 2011-09-30 | $N/A | -$3.24 | ||
| 2011-06-30 | 2011-06-30 | $N/A | -$1.67 | ||
| 2011-03-31 | 2011-03-31 | $N/A | -$1.28 | ||
| 2010-12-31 | 2010-12-31 | $N/A | -$0.89 | ||
| 2010-09-30 | 2010-09-30 | $N/A | -$0.75 | ||
| 2010-06-30 | 2010-06-30 | $N/A | -$0.69 | ||
| 2010-03-31 | 2010-03-31 | $N/A | -$0.36 | ||
| 2009-12-31 | 2009-12-31 | $N/A | -$0.40 | ||
| 2009-09-30 | 2009-09-30 | $N/A | $0.01 | ||
| 2009-06-30 | 2009-06-30 | $N/A | -$0.08 |
Titan Medical Inc (TMDI) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Research Development | 5.5 million | N/A | 121463 | 46119 | N/A |
| Income Before Tax | -20.63 million | N/A | -1.14 million | -768043 | N/A |
| Selling General Administrative | 2.42 million | N/A | 2.11 million | 1.53 million | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Ebit | -20.45 million | N/A | -855182 | -541251 | N/A |
| Operating Income | 1.93 million | N/A | 7.73 million | -1.59 million | N/A |
| Income Tax Expense | N/A | N/A | N/A | N/A | N/A |
| Total Revenue | 10 million | N/A | 10 million | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A |
| Total Other Income Expense Net | -22.54 million | N/A | -6.97 million | 1.19 million | N/A |
| Net Income From Continuing Operations | -20.63 million | N/A | -1.14 million | -768043 | N/A |
| Net Income Applicable to Common Shares | -20.63 million | -1.64 million | -1.14 million | N/A | 2.41 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | N/A | -47430 | -56130 | N/A | N/A |
| Change to Liabilities | -737993 | -3.65 million | N/A | -859873 | 40990 |
| Total Cash Flow from Investing Activities | -151790 | -47430 | N/A | -110391 | -168690 |
| Net Borrowings | -23518 | 1.49 million | N/A | -5100 | N/A |
| Total Cash Flow from Financial Activities | N/A | 20.77 million | 3.47 million | N/A | 2.58 million |
| Change to Operating Activities | N/A | N/A | N/A | N/A | N/A |
| Change in Cash | N/A | 26.93 million | 945727 | N/A | -9.15 million |
| Total Cash from Operating Activities | -4.58 million | 6.21 million | -2.47 million | -2.05 million | -11.56 million |
| Depreciation | N/A | 35475 | 14095 | N/A | 7300 |
| Other Cash Flow from Investing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Inventory | N/A | N/A | N/A | N/A | N/A |
| Change to Account Receivables | N/A | N/A | N/A | N/A | 6.5 million |
| Other Cash Flow from Financing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Net Income | -2.5 million | 11.73 million | N/A | -5.74 million | -16.55 million |
| Capital Expenditures | N/A | 47430 | 56130 | N/A | N/A |
Balance Sheet:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Total Liabailities | 43.65 million | N/A | 30.26 million | 12.58 million | N/A |
| Total Stockholder Equity | -13.81 million | N/A | 2.08 million | -8.39 million | N/A |
| Other Current Liabilities | 36.76 million | 14.7 million | 19.77 million | 2.37 million | N/A |
| Total Assets | 29.84 million | N/A | 32.35 million | 4.2 million | N/A |
| Common Stock | 215.82 million | 213.09 million | 210.1 million | N/A | 194.86 million |
| Other Current Assets | 765599 | 481400 | N/A | N/A | N/A |
| Retained Earnings | -239.03 million | -218.4 million | -216.76 million | -215.61 million | -214.84 million |
| Other Liabilities | N/A | N/A | N/A | N/A | N/A |
| Other Assets | N/A | N/A | N/A | N/A | N/A |
| Cash | 25.47 million | N/A | 28.69 million | 1.76 million | N/A |
| Total Current Liabilities | 42.9 million | 24.11 million | 28.24 million | 12.58 million | N/A |
| Other Stockholder Equity | N/A | N/A | N/A | N/A | N/A |
| Property, Plant & Equipment | 1.11 million | 488853 | 440328 | N/A | 30394 |
| Total Current Assets | 26.95 million | 25.94 million | 30.22 million | 2.52 million | N/A |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | -15.59 million | 1.97 million | 395485 | N/A | -13.28 million |
| Short Term Investments | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | 1.65 million | N/A | N/A |
| Inventory | N/A | N/A | N/A | N/A | N/A |
| Accounts Payable | 4.08 million | 7.64 million | N/A | N/A | N/A |
Titan Medical Inc (TMDI) Chart:
Titan Medical Inc (TMDI) News:
Below you will find a list of latest news for Titan Medical Inc (TMDI) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Titan Medical Inc (TMDI) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Latest TMDI Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:34 PM EST | 800 | $0.47 |
| Jun 13, 2022 7:40 PM EST | 100 | $0.47 |
| Jun 13, 2022 7:54 PM EST | 200 | $0.47 |
| Jun 13, 2022 7:59 PM EST | 3 | $0.4703 |
| Jun 13, 2022 7:59 PM EST | 1 | $0.4703 |
Titan Medical Inc (TMDI) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-25 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/840551/999999999520001541/9999999995-20-001541-index.htm |
| 2020-06-05 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/840551/000000000020005046/0000000000-20-005046-index.htm |
| 2020-05-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/840551/000091957420003347/0000919574-20-003347-index.htm |
| 2020-06-18 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/840551/000091957420004202/0000919574-20-004202-index.htm |
| 2019-11-07 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752319002228/0001157523-19-002228-index.htm |
| 2019-11-21 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752319002296/0001157523-19-002296-index.htm |
| 2019-12-04 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752319002322/0001157523-19-002322-index.htm |
| 2019-12-17 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752319002349/0001157523-19-002349-index.htm |
| 2019-12-18 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752319002353/0001157523-19-002353-index.htm |
| 2019-12-23 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752319002368/0001157523-19-002368-index.htm |
| 2019-12-23 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/840551/000115752319002369/0001157523-19-002369-index.htm |
| 2019-12-23 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752319002370/0001157523-19-002370-index.htm |
| 2020-01-06 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320000015/0001157523-20-000015-index.htm |
| 2020-01-27 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320000104/0001157523-20-000104-index.htm |
| 2020-02-03 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320000132/0001157523-20-000132-index.htm |
| 2020-02-11 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320000179/0001157523-20-000179-index.htm |
| 2020-03-25 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320000416/0001157523-20-000416-index.htm |
| 2020-03-25 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320000418/0001157523-20-000418-index.htm |
| 2020-03-26 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320000423/0001157523-20-000423-index.htm |
| 2020-03-27 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/840551/000115752320000428/0001157523-20-000428-index.htm |
| 2020-03-27 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320000429/0001157523-20-000429-index.htm |
| 2020-03-27 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320000432/0001157523-20-000432-index.htm |
| 2020-03-31 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320000448/0001157523-20-000448-index.htm |
| 2020-04-29 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320000593/0001157523-20-000593-index.htm |
| 2020-04-30 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320000614/0001157523-20-000614-index.htm |
| 2020-04-30 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320000624/0001157523-20-000624-index.htm |
| 2020-05-04 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320000639/0001157523-20-000639-index.htm |
| 2020-05-05 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/840551/000115752320000665/0001157523-20-000665-index.htm |
| 2020-05-05 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320000666/0001157523-20-000666-index.htm |
| 2020-05-06 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320000675/0001157523-20-000675-index.htm |
| 2020-05-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320000741/0001157523-20-000741-index.htm |
| 2020-05-15 | 6-K/A | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320000754/0001157523-20-000754-index.htm |
| 2020-05-20 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/840551/000115752320000785/0001157523-20-000785-index.htm |
| 2020-05-27 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320000812/0001157523-20-000812-index.htm |
| 2020-06-01 | F-1 | Registration statement for certain foreign private issuers | https://www.sec.gov/Archives/edgar/data/840551/000115752320000839/0001157523-20-000839-index.htm |
| 2020-06-03 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320000851/0001157523-20-000851-index.htm |
| 2020-06-04 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320000863/0001157523-20-000863-index.htm |
| 2020-06-04 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320000865/0001157523-20-000865-index.htm |
| 2020-06-05 | 6-K/A | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320000866/0001157523-20-000866-index.htm |
| 2020-06-08 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320000873/0001157523-20-000873-index.htm |
| 2020-06-09 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320000879/0001157523-20-000879-index.htm |
| 2020-06-10 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320000885/0001157523-20-000885-index.htm |
| 2020-06-10 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/840551/000115752320000886/0001157523-20-000886-index.htm |
| 2020-06-10 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320000887/0001157523-20-000887-index.htm |
| 2020-06-11 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320000894/0001157523-20-000894-index.htm |
| 2020-06-11 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320000896/0001157523-20-000896-index.htm |
| 2020-06-15 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320000901/0001157523-20-000901-index.htm |
| 2020-06-22 | F-1/A | Registration statement for certain foreign private issuers | https://www.sec.gov/Archives/edgar/data/840551/000115752320000919/0001157523-20-000919-index.htm |
| 2020-06-22 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320000922/0001157523-20-000922-index.htm |
| 2020-06-23 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/840551/000115752320000928/0001157523-20-000928-index.htm |
| 2020-06-25 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320000932/0001157523-20-000932-index.htm |
| 2020-07-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320000972/0001157523-20-000972-index.htm |
| 2020-07-22 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/840551/000115752320001022/0001157523-20-001022-index.htm |
| 2020-07-27 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320001034/0001157523-20-001034-index.htm |
| 2020-07-30 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320001072/0001157523-20-001072-index.htm |
| 2020-08-11 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320001165/0001157523-20-001165-index.htm |
| 2020-08-12 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320001176/0001157523-20-001176-index.htm |
| 2020-08-13 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/840551/000115752320001183/0001157523-20-001183-index.htm |
| 2020-09-08 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320001235/0001157523-20-001235-index.htm |
| 2020-09-08 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320001237/0001157523-20-001237-index.htm |
| 2020-09-09 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320001240/0001157523-20-001240-index.htm |
| 2020-09-17 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320001257/0001157523-20-001257-index.htm |
| 2020-09-21 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320001261/0001157523-20-001261-index.htm |
| 2020-10-01 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320001282/0001157523-20-001282-index.htm |
| 2020-10-07 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320001294/0001157523-20-001294-index.htm |
| 2020-10-26 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000115752320001340/0001157523-20-001340-index.htm |
| 2019-11-15 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/840551/000119312519293033/0001193125-19-293033-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/840551/000119312520038145/0001193125-20-038145-index.htm |
| 2020-04-02 | 20-F | Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/840551/000119312520095558/0001193125-20-095558-index.htm |
| 2020-04-02 | 20-F/A | Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/840551/000119312520095647/0001193125-20-095647-index.htm |
| 2020-04-03 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/840551/000121390020008565/0001213900-20-008565-index.htm |
| 2020-03-25 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/840551/000153561020000082/0001535610-20-000082-index.htm |
| 2020-06-25 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/840551/999999999520001541/9999999995-20-001541-index.htm |